Diet, nutrition, and hormone therapy for prostate cancer: a systematic review with implications for future interventions
This comprehensive review of diet and ADT in prostate cancer identified nutritional interventions that were safe, feasible, and may be recommended as part of prostate cancer treatment and survivorship. Future RCTs should evaluate optimal diet duration, longer follow-up, multidisciplinary patient support, and novel anti-metabolic therapies like GLP-1RA.
Authors
- Raynald Samoa (ORCID: https://orcid.org/0000-0002-7208-8764)
- Mina S. Sedrak (ORCID: https://orcid.org/0000-0002-8379-391X)
- Jonathan Shih (ORCID: https://orcid.org/0000-0002-8651-7806)
- Luca Valle (ORCID: https://orcid.org/0000-0002-5781-4174)
- Nicole V. DeVille (ORCID: https://orcid.org/0000-0002-2199-8805)
- Sasha Ebrahimi
- Amar U. Kishan (ORCID: https://orcid.org/0000-0002-4836-8483)
- Paul Tominez
- Kekoa Taparra
- Matthew Calumpit (ORCID: https://orcid.org/0009-0005-5479-8331)
- Michael Steinberg
- Tannaz Moin
- Isabella Pahulu
- Patricia A Ganz
Institutions
- Los Angeles County Department of Public Health (US)
- University City Science Center (US)
- University of Nevada, Las Vegas (US)
- University of California, Los Angeles (US)
- University of California, San Francisco (US)
- Tripler Army Medical Center (US)
- City of Hope (US)
- VA Greater Los Angeles Healthcare System (US)
- University of Pennsylvania (US)
- Philadelphia University (US)
- Stanford University (US)
Publication Details
- Journal
- JNCI Cancer Spectrum
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1093/jncics/pkag014
- Primary Topic
- Cancer Risks and Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00